Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 207.00M | $ 223.00M | $ 252.00M | $ 144.00M | $ 173.00M |
Total Assets | $ 4.95B | $ 5.19B | $ 5.21B | $ 5.06B | $ 5.11B |
Total Debt | $ 1.95B | $ 1.99B | $ 2.06B | $ 2.19B | $ 2.32B |
Net Debt | $ 1.74B | $ 1.77B | $ 1.81B | $ 2.04B | $ 2.15B |
Total Liabilities | $ 2.81B | $ 2.97B | $ 3.10B | $ 3.15B | $ 3.43B |
Stockholders Equity | $ 2.14B | $ 2.23B | $ 2.10B | $ 1.91B | $ 1.68B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |